Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization

被引:12
|
作者
Rathmann, Nils [1 ]
Kara, Kerim [2 ]
Budjan, Johannes [1 ]
Henzler, Thomas [1 ]
Smakic, Arman [1 ]
Schoenberg, Stefan O. [1 ]
Diehl, Steffen J. [1 ]
机构
[1] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Inst Clin Radiol & Nucl Med, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany
[2] Heidelberg Univ, Med Fac Mannheim, Fraunhofer Project Grp Automat Med & Biotechnol, Mannheim, Germany
关键词
PLBV; DEB TACE; HCC; cone beam CT; COMPUTED-TOMOGRAPHY; TUMOR RESPONSE; PREDICTION;
D O I
10.21873/anticanres.12004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Prospective comparison of cone beam C-Arm CT based parenchymal liver blood volume (PLBV) and dynamic volume perfusion CT (dVPCT) measurements in patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolisation (TACE) with drug-eluting beads (DEB). Patients and Methods: In 16 patients, changes of PLBV and dVPCT measurements [ arterial liver parenchyma (ALP); temporal maximum intensity projection (MIP); hepatic perfusion index (HPI); portal venous parenchyma] were correlated to one another and to the modified Response Evaluation Criteria in Solid Tumors (mRECIST). Results: After TACE, the following parameters showed a statistically significant change (p< 0.05) in mean value: PLBV: -4.85 ml/100 ml, ALP: -4.14 ml/100 ml/min, MIP: -0.23 Houndsfield units, HPI: -5.39%, and mRECIST: -20.53 mm. Pre-to-post TACE differences in PLBV showed only weak to very weak correlation to dVPCT parameters (r(2)< 0.24). Conclusion: Although PLBV and dVPCT parameters showed only a weak to very weak correlation, both methods validly assessed changes in arterial tumor vascularity after DEB TACE.
引用
收藏
页码:5681 / 5685
页数:5
相关论文
共 50 条
  • [31] Effect of acute kidney injury on the patients with hepatocellular carcinoma undergoing transarterial chemoembolization
    Sohn, Won
    Ham, Cheol Bae
    Kim, Nam Hee
    Kim, Hong Joo
    Cho, Yong Kyun
    Jeon, Woo Kyu
    Kim, Byung Ik
    PLOS ONE, 2020, 15 (12):
  • [32] Selecting a prognostic renal surrogate for patients with hepatocellular carcinoma undergoing transarterial chemoembolization
    Lee, Yun-Hsuan
    Hsu, Chia-Yang
    Huang, Yi-Hsiang
    Su, Chien-Wei
    Lin, Han-Chieh
    Lee, Rheun-Chuan
    Chiou, Yi-You
    Huo, Teh-Ia
    Lee, Shou-Dong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (10) : 1581 - 1588
  • [33] Prognostic Significance of Tumor Characteristics in Patients Undergoing Transarterial Chemoembolization for Hepatocellular Carcinoma
    Abdalla, Abubaker
    Taha, Wesam
    Abdellatief, Amro
    Burton, M. Caroline
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S567 - S568
  • [34] Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: Comparison with transarterial chemoembolization
    Seo, Dong Dae
    Lee, Han Chu
    Jang, Myoung Kuk
    Min, Hyun Ju
    Kim, Kang Mo
    Lim, Young Suk
    Chung, Young-Hwa
    Lee, Yung Sang
    Suh, Dong Jin
    Ko, Gi-Young
    Lee, Young-Joo
    Lee, Sung-Gyu
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (12) : 3501 - 3509
  • [35] Preoperative Portal Vein Embolization and Surgical Resection in Patients with Hepatocellular Carcinoma and Small Future Liver Remnant Volume: Comparison with Transarterial Chemoembolization
    Dong Dae Seo
    Han Chu Lee
    Myoung Kuk Jang
    Hyun Ju Min
    Kang Mo Kim
    Young Suk Lim
    Young-Hwa Chung
    Yung Sang Lee
    Dong Jin Suh
    Gi-Young Ko
    Young-Joo Lee
    Sung-Gyu Lee
    Annals of Surgical Oncology, 2007, 14 : 3501 - 3509
  • [36] The predictive value of metabolic tumor volume on FDG PET for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma
    Lee, Jeong Won
    Yun, Mijin
    Cho, Arthur
    Kang, Won Jun
    Lee, Jong Doo
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [37] Parenchymal Blood Volume Assessed by C-Arm-Based Computed Tomography in Immediate Posttreatment Evaluation of Drug-Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma
    Syha, Roland
    Groezinger, Gerd
    Grosse, Ulrich
    Maurer, Michael
    Zender, Lars
    Horger, Marius
    Nikolaou, Konstantin
    Ketelsen, Dominik
    INVESTIGATIVE RADIOLOGY, 2016, 51 (02) : 121 - 126
  • [38] Multivariate Analysis of the Predictors of Survival for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Focusing on Superselective Chemoembolization
    Ji, Suk Kyeong
    Cho, Yun Ku
    Ahn, Yong Sik
    Kim, Mi Young
    Park, Yoon Ok
    Kim, Jae Kyun
    Kim, Wan Tae
    KOREAN JOURNAL OF RADIOLOGY, 2008, 9 (06) : 534 - 540
  • [39] Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Wang, Hongyu
    Lin, Chuyang
    Fan, Wenzhe
    Zhang, Jiang
    Zhang, Yingqiang
    Yao, Wang
    Li, Jiaping
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3433 - 3444
  • [40] Blood Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
    Huang, Zhi-Liang
    Luo, Jun
    Chen, Min-Shan
    Li, Jin-Qing
    Shi, Ming
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2011, 22 (05) : 702 - 709